Michael Thick Joins IMS MAXIMS

IMS MAXIMSRenowned health informatics leader Michael Thick has this week been appointed as chief medical officer (CMO) and chief clinical information officer (CCIO) of electronic patient record software pioneer IMS MAXIMS.

Well known for his position as chief clinical officer on the National Programme for Information Technology, he has been instrumental across various successful clinical, informatics and research initiatives, including the introduction of the 'clinical five' into the Department of Health's 2008 health informatics review - a basis for fundamental clinical functionality within a hospital today.

The former surgeon and clinical informatics lead at the Department of Health will lead the company's continued focus on clinical excellence and apply his valuable insight and experience into software design, product development and change programmes for healthcare providers.

"I will offer a deeper understanding of the NHS, specifically around clinical processes for IMS MAXIMS’ customers, whilst supporting the development of clinical governance within the product portfolio to ensure they are safe and effective," said Thick.

Commenting on his appointment by IMS MAXIMS, Thick said: “It is a highly ambitious company driving innovation and change that is developing its strong reputation within the health service.

"I was attracted by the company’s clear understanding of the way healthcare needs to develop and its deep knowledge of business transformation to support sustainable new models of clinical care. It is an agile organisation that is able to change and adapt quickly where necessary to produce the correct tools for clinicians to deliver safer care."

On the role of electronic patient record (EPR) technology in the NHS, Thick said: "EPRs are essential to clinical practice. If we are going to achieve improvements in the quality of healthcare in terms of outcomes and patient experience, and redesign the NHS to become more clinically-based, then the only piece of technology that will be able to support those needs is an electronic patient record."

For IMS MAXIMS, the appointment of Thick represents a long-term commitment to develop and innovate healthcare software systems and applications that enhance patient safety and outcomes and support the delivery of best practice.

The company has been pioneering in the use of open source software after releasing the software code to become the first open source electronic patient record provider in the UK.

Its openMAXIMS solution is currently being deployed at Taunton and Somerset NHS Foundation Trust, which is due to become the first acute NHS trust to implement an open source EPR later this year. In January it was announced that UK private hospital provider, Ramsay Healthcare, was partnering with IMS MAXIMS for 10 years after signing an agreement to use its open source EPR and clinical modules to improve patient satisfaction and outcomes.

"Clinical safety should be at the heart of any healthcare software," said Shane Tickell, chief executive of IMS MAXIMS. "We've held that as our company ethos since the beginning and have continued to innovate and develop our solutions alongside clinicians over nearly 30 years. We welcome Michael to our growing team of talented individuals as we continue to recruit quality personnel committed to improving patient outcomes."

Thick's 30-plus years' clinical and informatics experience has been built over a decorated career in the public sector. During his time at the Department of Health, he also served as senior medical advisor to the Choose and Book and PACS (picture archiving and communication system) programmes. The former consultant transplant surgeon has developed many clinically-led systems, including working with the end of life team at The Royal Marsden NHS Foundation Trust to co-design Coordinate My Care, a shared end of life care register.

His achievements at a national level have been preceded by an established career within clinical practice. After qualifying as a doctor in 1976 from Cambridge University, he went on to become director of liver and renal transplantation at the Freeman Hospital in Newcastle, and served as chairman of the IM&T Strategy Committee for the city’s hospitals.

Until recently a professor of genomics at Imperial College London, Thick spent ten years researching the use of genomics and data mining big phenotypic datasets, techniques which will require EPRs to deliver personalised medicine. Other achievements include being appointed senior registrar to Professor Sir Roy Calne in Cambridge, and setting up several transplant units across the NHS. He is currently a member of the Digital Health Chief Clinical Information Officer (CCIO) Leaders Network.

About IMS MAXIMS
IMS MAXIMS is an open source and proprietary electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations and 11 million patient records in the UK. In Ireland, there are 20,000 users of IMS MAXIMS products, where it supports 1.9 million patient records, representing around 50% of the population.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...